Information contained on this page is provided by an independent third-party content provider. Frankly and this Site …
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site …
Myriad Genetics Inc. (MYGN) recently announced its intention to present data from four clinical studies undertaken with Prolaris, at the 14th Annual Meeting of the Society for Urologic Oncology (:SUO) in Bethesda, MD. Additionally data …